We are an experienced real estate team led by GMP expertise.
GeneSuites is a development and strategic partner that removes barriers for life science companies beginning phase II-III clinical trials or seeking to enter the U.S. market. In partnership with industry experts and validated by third-party reviewers, GeneSuites was founded in 2020 with a novel solution to address the imbalance in supply and demand for biomanufacturing capacity while offering critical PD and cGMP manufacturing advantages.
We specialize in advancing biomanufacturing strategies from beginning to end.
-
Site Procurement
-
Financing
-
Development & Construction
-
Operational Expertise
Meet Our Team
Steve Scott
Managing Partner
Doug Lozier
Chief Investment Officer
Gary Schoenhouse, P.E.
Chief Technical Advisor
Maclain Caldwell
Chief Financial Officer
Jeannie Ma
Director, Marketing & Communications
Our team has worked in partnership with some of the top life science and bioscience companies
